Phase Forward Executives to Present in Key Panels at DIA's 42nd Annual Meeting; To Share Insights on the Benefits of EDC and the Power of Innovative Safety Management Solutions

Phase Forward (NASDAQ: PFWD), a leading provider of datamanagement solutions for clinical trials and drug safety, todayannounced that the company will participate at the 42nd Annual Meetingof the Drug Information Association (DIA), June 18-22 at thePennsylvania Convention Center in Philadelphia. In addition toexhibiting its technologies, company executives will present in sixkey panels. Session details are as follows:
WHO: Robbert P. van Manen, Worldwide Technical Director (Session
Chair)
WHAT: "Collaborative Clinical Study Database Design" Panel
WHEN: Monday, June 19, 3:30-5:00 p.m.

WHO: Paul A. Bleicher, Chairman and Founder (Session Chair)
WHAT: "Combining EHR and EDC: Finding the Right IT Architecture"
Panel
WHEN: Tuesday, June 20, 10:30 a.m.-12:00 p.m.

WHO: David Fishbach, Consulting Manager
WHAT: "GCP/QA Town Meeting: Meeting with GCP Challenges of
Electronic Data Capture (EDC)" Panel
WHEN: Tuesday, June 20, 1:30-3:00 p.m.

WHO: Mark Wren, Director of International eServices Support
WHAT: "Clinical Trials in Central and Eastern Europe: Overcoming
Technology and Logistical Challenges" Panel
WHEN: Wednesday, June 21, 8:30-10:00 a.m.

WHO: Wayne R. Kubick, Vice President, Lincoln Technologies, Phase
Forward Drug Safety Division
WHAT: "Where Are We in the Debate Between the Biopharmaceutical
Industry, the Solution Providers and the Regulatory Authorities?
What Initiatives Are Being Taken to Alleviate Issues around
eSource?" Panel
WHEN: Wednesday, June 21, 8:30-10:00 a.m.

WHO: Barry Burnstead, Head of International Commercial Development
(Session Chair) and Robbert P. van Manen, Worldwide Technical
Director
WHAT: "The Safety-clinical Data Management Interface" Panel
WHEN: Wednesday, June 21, 10:30 a.m.-12:00 p.m.

On Monday, Mr. van Manen will lead a panel that focuses on therequirements for a collaborative infrastructure based on componentlibraries to support global cooperation in the design andimplementation of clinical study databases.

On Tuesday, Dr. Bleicher will chair a session on electronic healthrecords (EHR) and electronic data capture (EDC) integration, focusingon the benefits and complexities of integration. Also on Tuesday, Mr.Fishbach will participate in a panel that shares real worldexperiences - successes and lessons learned - relating to the use ofEDC in global trials.

On Wednesday, Mr. Wren will take part in a panel that willinvestigate new technologies such as medical imaging standardizationand central collection as part of a global clinical developmentprogram - specifically in Central and Eastern Europe where clinicaltrials are benefiting increasingly from these technologies. Mr. Kubickwill participate in an eSource panel that focuses on industry issuesand the development of recommendations relevant to the eSource DataInterchange (eSDI) for clinical trials, as detailed by the group'spreviously issued whitepaper. And finally, Mr. Burnstead will chair apanel that will cover standards in both safety and clinical datamanagement (CDM) databases in which Mr. van Manen will alsoparticipate. They will discuss the effects increased regulatorypressures and technological advances, including EDC, have had on thedynamics of serious adverse event (SAE) capture and notification.

In addition, Phase Forward will showcase its EDC, CDMS and safetymanagement technologies at booth #1427. Specific demos will includethe company's newly launched Central Coding for InForm(TM) product,along with its most recent award-winning Clinical Trials SignalDetection (CTSD(TM)) solution. Members of the media interested inspeaking with Phase Forward at the event should contact Juli Greenwoodat CHEN PR at 781-672-3137 or jgreenwood@chenpr.com. For additionalconference information, please visit: http://www.diahome.org/en/.

About Phase Forward

Phase Forward is a leading provider of integrated data managementsolutions for clinical trials and drug safety. The company offersproven solutions for electronic data capture (InForm(TM)), clinicaldata management (Clintrial(TM)), clinical trials signal detection(CTSD(TM)), strategic pharmacovigilance (WebVDME(TM) and SignalManagement), adverse event reporting (Clintrace(TM)) and applied datastandards (WebSDM). In addition, the company provides services in theareas of application implementation, hosting and validation, dataintegration, business process optimization, safety data management andindustry standards. Phase Forward's products and services have beenutilized in over 10,000 clinical trials involving more than 1,000,000clinical trial study participants at over 230 organizations andregulatory agencies worldwide including: AstraZeneca, Biogen Idec,Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, Food andDrug Administration, GlaxoSmithKline, Guidant, Merck, U.K. Medicinesand Healthcare Products Regulatory Agency, National Institutes ofHealth, Procter & Gamble, Quintiles, sanofi-aventis, Schering-PloughResearch Institute and Serono. Additional information about PhaseForward is available at www.phaseforward.com